eLife Assessment
This study constitutes a fundamental advance for the uveal melanoma research field that might be exploited to target this deadly cancer and, more generally, for targeting transcriptional dependency in cancers. This work substantially advances our understanding of pharmacological inhibition of SWI/SNF as a therapeutic approach for cancer. The study is well written and provides compelling evidence, including comprehensive datasets, compound screens, gene expression analysis, epigenetics, as well as animal studies.